Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US patent for simple, low-cost nucleic acid test:

This article was originally published in Clinica

Executive Summary

Molecular Innovations has received a US patent covering its portable, easy-to-use, self-contained system for isolating, amplifying and sequencing DNA or RNA. The system, which can be used to detect specific nucleic acid sequences corresponding to genetically-linked diseases, may provide an economical and simple point-of-care tool for detecting disease predisposition and for monitoring patient response to treatment. The device could overcome the cost and ease-of-use hurdles of transferring nucleic acid-based testing to routine clinical or field testing faced by other methods currently used for genetic testing, said the Denver, Colorado-based company.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT079843

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel